Portal:COVID-19/FeaturedPathways
From WikiPathways
Contents[hide] |
SARS-CoV-2 Pathways
Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist Type I Interferon Induction and Signaling During SARS-CoV-2 Infection The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist COVID-19, thrombosis and anticoagulation |
Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor : Molecular mechanisms and potential therapeutic target |
Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist STING pathway in Kawasaki-like disease and COVID-19 (Homo sapiens) |
Image does not exist RAS and Bradykinin pathways in COVID-19 (Homo sapiens) | ||
Image does not exist nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell | |||
Image does not exist Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens) |
Image does not exist SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (Homo sapiens) | ||
Other coronaviruses: MERS, SARS-CoV, etc
Lipid metabolism alternations that are related to infection by the corona virus. | |||
More about ACE2
Image does not exist ACE Inhibitor Pathway |
Pathways from Reactome
List of featured pathways:
- Pathway:WP4846
- Pathway:WP4860
- Pathway:WP4868
- Pathway:WP4927
- Pathway:WP4876
- Pathway:WP4883
- Pathway:WP4891
- Pathway:WP4884
- Pathway:WP4904
- Pathway:WP4936